Tradestie Institutional Equity Comparison Engine
SILO vs MAIA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MAIA Overall Edge
MAIA Captures Institutional Edge (2โ1 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MAIA Biotechnology, Inc. (MAIA) driven by superior Valuation, Growth & Margin while SILO counters with relative strength in Momentum & Technical. Fundamentally, SILO trades at N/M Forward P/E with -8250.5% operating margin (+0.0% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SILO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
MAIA
SILO N/M vs MAIA 1.2x Fwd P/E
Growth & Margin Winner
MAIA
Op Margin -8250.5% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
SILO
1Y +332.9% vs +20.6% ยท 52W Pos 19% vs 10%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SILO
NASDAQ
Silo Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.71
-9.04% 1D
Market Cap
$4.1M
1M Return
+44.92%
1Y Return
+332.91%
Forward P/E
N/M
Unified AI Score
29.9 / 100
SELL
Tech 50.0
Fund 31.0
Flow 50.0
Mom 50.0
MAIA
NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap
$68.5M
1M Return
-1.77%
1Y Return
+20.65%
Forward P/E
1.2x
Unified AI Score
37.6 / 100
SELL
Tech 40.0
Fund 38.0
Flow 50.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SILO +332.91%
MAIA +20.65%
Spread: +312.26 pp (SILO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
SILO TTM Op. Margin: -8250.5%
MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SILO vs MAIA. Trailing 12-month operating profitability (SILO -8250.5% vs MAIA 0.0%) and valuation multiples (SILO N/M vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SILO | MAIA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.1M | $68.5M | Larger Scale | MAIA |
| Trailing P/E Ratio Valuation | N/M | 1.2x | Lower Multiple | MAIA |
| Forward P/E Ratio Valuation | N/M | 1.2x | Lower Multiple | MAIA |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | -8250.5% | 0.0% | Higher Margin | MAIA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -91.2% | -341.5% | Higher ROE | SILO |
| 52-Week Range Position Momentum | 19% ($0โ$8) | 10% ($1โ$3) | Stronger Trend | SILO |
| Beta / 30D Volatility Risk Regime | -6.73ฮฒ ยท 123% Vol | 1.65ฮฒ ยท 108% Vol | Lower Realized Risk | MAIA |
| Unified Institutional Score Composite Signal | 29.9 / 100 (SELL) | 37.6 / 100 (SELL) | Higher Composite | MAIA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SILO vs MAIA Buy Guide
SILO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MAIA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SILO nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.